These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3562040)

  • 1. Plasma protein in dengue hemorrhagic fever/dengue shock syndrome.
    Suminta ; Soenarto Y; Widiarto ; Sutaryo ; Ismangoen
    Paediatr Indones; 1986; 26(3-4):56-61. PubMed ID: 3562040
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological manifestations in dengue hemorrhagic fever.
    Rajajee S; Mukundan D
    Indian Pediatr; 1994 Jun; 31(6):688-90. PubMed ID: 7896395
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity.
    Koraka P; Murgue B; Deparis X; Van Gorp EC; Setiati TE; Osterhaus AD; Groen J
    J Med Virol; 2004 Mar; 72(3):445-50. PubMed ID: 14748068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on dengue hemorrhagic fever. II. Electrolyte study.
    Varavithya W; Manu P; Kittikool J; Phongbetchara P; Kashemsant C
    J Med Assoc Thai; 1973 Jan; 56(1):15-23. PubMed ID: 4685995
    [No Abstract]   [Full Text] [Related]  

  • 5. The behavior of transfused platelets in dengue hemorrhagic fever.
    Isarangkura P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():222-4. PubMed ID: 7886581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and dengue haemorrhagic fever.
    Usawattanakul W; Nimmannitya S; Sarabenjawong K; Tharavanij S
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):8-12. PubMed ID: 3738611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.
    Bokisch VA; Top FH; Russell PK; Dixon FJ; Müller-Eberhard HJ
    N Engl J Med; 1973 Nov; 289(19):996-1000. PubMed ID: 4742219
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections.
    Mairuhu AT; Peri G; Setiati TE; Hack CE; Koraka P; Soemantri A; Osterhaus AD; Brandjes DP; van der Meer JW; Mantovani A; van Gorp EC
    J Med Virol; 2005 Aug; 76(4):547-52. PubMed ID: 15977234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorrhagic fever and the dengue shock syndrome].
    Ramos C; García H; Villaseca JM
    Salud Publica Mex; 1993; 35(1):39-55. PubMed ID: 8470020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic derangement in dengue hemorrhagic fever in children.
    Isarangkura PB; Bintadish P; Pongpanich B; Phanichyakarn P; Valyasevi A
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):138-40. PubMed ID: 3738601
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical observations on hospitalized patients with virologically confirmed dengue hemorrhagic fever in Jakarta, Indonesia 1975-1983.
    Sumarmo ; Wuryadi S; Gubler DJ
    Paediatr Indones; 1986; 26(7-8):137-51. PubMed ID: 3774341
    [No Abstract]   [Full Text] [Related]  

  • 12. The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations.
    Dietz V; Gubler DJ; Ortiz S; Kuno G; Casta-Vélez A; Sather GE; Gómez I; Vergne E
    P R Health Sci J; 1996 Sep; 15(3):201-10. PubMed ID: 8994286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity in children with dengue hemorrhagic fever.
    Tuchinda C; Muarngmanee L
    J Med Assoc Thai; 1983 Mar; 66(3):166-8. PubMed ID: 6343541
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical differences among PCR-proven dengue serotype infections.
    Limkittikul K; Yingsakmongkon S; Jittmittraphap A; Chuananon S; Kongphrai Y; Kowasupathr S; Rojanawatsirivit C; Mammen MP; Jampangern W
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1432-8. PubMed ID: 16610645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever.
    Bethell DB; Gamble J; Pham PL; Nguyen MD; Tran TH; Ha TH; Tran TN; Dong TH; Gartside IB; White NJ; Day NP
    Clin Infect Dis; 2001 Jan; 32(2):243-53. PubMed ID: 11170914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desialylation of plasma proteins in severe dengue infection: possible role of oxidative stress.
    Rajendiran S; Lakshamanappa HS; Zachariah B; Nambiar S
    Am J Trop Med Hyg; 2008 Sep; 79(3):372-7. PubMed ID: 18784228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of dengue shock syndrome in children.
    Tantracheewathorn T; Tantracheewathorn S
    J Med Assoc Thai; 2007 Feb; 90(2):272-7. PubMed ID: 17375631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
    Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
    J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemorrhagic dengue with shock in children in French Polynesia].
    Mallet EC; Gestas P; Pilorget H; Bataille H
    Bull Soc Pathol Exot; 1993; 86(5 Pt 2):450-4. PubMed ID: 7819799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on dengue hemorrhagic fever. Clinical study: an evaluation of steroids as a treatment.
    Pongpanich B; Bhanchet P; Phanichyakarn P; Valyasevi A
    J Med Assoc Thai; 1973 Jan; 56(1):6-14. PubMed ID: 4685999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.